Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by AEGIS LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 18, 2025
Income
$60,000.00
Expenses
Not reported
Registrant
AEGIS LLC
Filing UUID
afbfccc5-1bb3-4398-b9c3-97173a188c49
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Pharmacy Benefit Manager (PBM) issues and reform. 340B. IRA implementation. H.R.1492: Ensuring Pathways to Innovative Cures (EPIC) Act. Drug pricing. Most-Favored Nation (MFN) International reference pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542 - DRUG Act. H.R.830 - HELP Copays Act.

Literal federal measure citations: H.R.1492, H.R.5378, H.R.5376, H.R.6283, S.1542, H.R.830

HCR · Health Issues

General health care issues.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.